Kolexia
Bera Guillaume Oncologie radiothérapie
Bera Guillaume
Oncologie radiothérapie
Hôpital du Scorff
Lorient, France
70 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Tumeurs du sein Tumeurs osseuses Tumeurs de l'oesophage Douleur cancéreuse

Collaborateurs

Voir plus
Sire Christian
Sire Christian
Hôpital du Scorff, Lorient, France
Graziana Jean-Pierre
Graziana Jean-Pierre
Clinique Mutualiste Porte De L'orient, Lorient, France
Chéneau Caroline
Chéneau Caroline
Sgsm Onco, Cesson-Sévigné, France
Debras Bertrand
Debras Bertrand
Clinique Mutualiste Porte De L'orient, Lorient, France

Industries

Voir plus
Janssen
20 collaboration(s)
Dernière en 2023
Ipsen
16 collaboration(s)
Dernière en 2023
B3TSI
14 collaboration(s)
Dernière en 2023
A+A
12 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ROMANCE: Prospective Study of Omission of Whole-breast Radiotherapy Following Breast-conserving Surgery in Patients With Very Low Risk Ductal Carcinoma in Situ of the Breast
Essai Clinique (Unicancer)   11 décembre 2023
Bladder-ART: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Essai Clinique (Unicancer)   09 novembre 2023
Clinical research in general hospital centres in France, strengths and weaknesses.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   10 août 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Clinical and translational radiation oncology   08 mars 2023
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
European journal of cancer (Oxford, England : 1990)   09 janvier 2023
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFIT.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   27 juin 2022
Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial: A Phase I/II Randomized Study to Determine the Maximum Tolerated Dose, Safety, Pharmacokinetics and Antitumor Activity of Debio 1143 Combined With Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Essai Clinique (Debiopharm)   22 juin 2022
Intermediate-risk prostate cancer treated with exclusive external irradiation: Focus on anatomical sites of recurrence in two French trials.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   14 juin 2022
914MO Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
The Lancet. Oncology   03 août 2020